Home > Insider Trading > Filing (0001144204-13-006436)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1426800	Ventrus Biosciences Inc	VTUS	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1374805	H Russell Ellison	99 Hudson Street 5Th Floor New York NY US 10013	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-02-04	9,376	$2.52	9,376	No	4	P	Direct
Common Stock	Acquisiton	2013-02-05	5,624	$2.59	15,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (right to buy)	$8.10	2022-01-15	60,000	60,000	Direct
Common Stock	Stock Options (right to buy)	$6.00	2020-12-22	573,599	573,599	Direct
Common Stock	Warrants (right to buy)	$7.69	2014-11-08	8,065	8,065	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2022-01-15	60,000	60,000	Direct
2020-12-22	573,599	573,599	Direct
2014-11-08	8,065	8,065	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.51 to $2.52, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.51 to $2.59, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The options vest 1/3 on 1/15/2013, and the remaining 2/3 will vest in equal installments on the first and second anniversaries after 1/15/2013.
The options vested 1/3 on 12/22/2010, and the remaining 2/3 will vest in equal installments on the first and second anniversaries after 12/22/2010.
The warrant vested in three installments on 3/21/2008 (2,689 shares), 3/21/2009 (2,688 shares) and 3/21/2010 (2,688 shares).